DOI: http://dx.doi.org/10.18203/2349-3933.ijam20184760

The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a tertiary care center, Gujarat, India

Bhavesh R. Sureja, Gaurav D. Bhambhani

Abstract


Background: The interaction of obstructive sleep apnoea (OSA) with vascular risk factors is known as syndrome Z which is also known as the metabolic syndrome or the insulin resistance syndrome and these include the hypertension, central obesity, insulin resistance and hyperlipidaemia. The objective of the present study was to investigate the prevalence and severity of syndrome Z at tertiary care center.

Methods: This prospective study was conducted among 40 eligible patients between May and July 2018 at the tertiary care center included adult patients >18years of age. Overnight fasting glucose and lipid levels were measured, and baseline anthropometric data recorded. All sleep studies were scored and reported by a sleep physician. OSA was deemed to be present if the respiratory disturbance index (RDI) was >5, with mild, moderate and severe categories classified according to the Chicago criteria.

Results: Mean age of participants was 52.7years, 77.5% were male, Mean BMI and waist circumference were 29.2kg/m2 and 113.8cm respectively. Almost 92.5% participants were known case of HTN, 85.0% were DM and 67.5% Dyslipidemia. Around 60.0% participants were belonged to severe grade of OSAS and 7 (17.5%) patients who fulfilled all five criteria for the diagnosis of the metabolic syndrome had severe OSAS. The prevalence of OSA in the entire group was 95.0%.

Conclusions: The prevalence of syndrome Z in present study participants was very high. With the help of history and polysomnogram, metabolic syndrome should be screened for OSA. Early diagnosis and treatment of OSA is the essential part in the treatment of metabolic syndrome and hence CAD.


Keywords


Metabolic syndrome, Obstructive sleep apnoea, Polysomnography, Severe obesity, Syndrome Z

Full Text:

PDF

References


Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax. 1998 Oct 1;53(suppl 3):S25-8.

Venkateswaran S, Shankar P. The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore. Postgrad Med J. 2007 May 1;83(979):329-31.

American Academy of Sleep Medicine ICSD-2: The International Classification of Sleep Disorders. Diagnostic and Coding Manuel. 2nd ed. 2005.

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. New Eng J Med. 1993 Apr 29;328(17):1230-5.

Bınıci DN, Kayabekir M, Tımur O, Sanıbas AV, Tasar PT. Prevalence of metabolic syndrome in patients with obstructive sleep apnea syndrome: a single center experience. Ann Clin Exp Metabol. 2016;1(1):1010.

Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004 Apr 28;291(16):2013-6.

Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults. executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-97.

National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143-421.

Perez EA, Oliveira LV, Freitas WR, Malheiros CA, Ilias EJ, Silva AS, et al. Prevalence and severity of syndrome Z in women with metabolic syndrome on waiting list for bariatric surgery: a cross-sectional study. Diabetol Metabolic Syndrome. 2017 Dec;9(1):72.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005 Oct 25;112(17):2735-52.

Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, Wichert PV. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiol. 1991;79(2):84-92.

Schroeder JS, Motta J, Guilleminault C. Hemodynamic studies in sleep apnea. In: Guilleminault C, Dement WC, eds. Sleep apnea syndromes. New York: Alan R Liss, 1978:177-196.

Hedner JA, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension? J. Hypertens. 1988;6(Suppl):5529-31.

Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1993 Jun 1;103(6):1763-8.

Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006 Dec;5(1):22.

Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004 May 1;25(9):735-41.

Lam JC, Lam B, Lam CL, Fong D, Wang JK, Tse HF, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respiratory Med. 2006 Jun 1;100(6):980-7.

Shiina K, Tomiyama H, Takata Y, Usui Y, Asano K, Hirayama Y, et al. Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertension Res. 2006 Jun;29(6):433.

Kozan O, Oguz A, Erol C, Senocak M, Ongen Z, Abacı A, et al. Results of METSAR. Metabolic Syndrome Research Group. Antalya: XX. National Congress of Cardiology. 2004.

Agrawal S, Sharma SK, Sreenivas V, Lakshmy R. Prevalence of metabolic syndrome in a north Indian hospital-based population with obstructive sleep apnoea. Indian J Med Res. 2011 Nov;134(5):639-44.

Barreiro B, Garcia L, Lozano L, Almagro P, Quintana S, Alsina M, et al. Obstructive sleep apnea and metabolic syndrome in spanish population. Open Respiratory Med J. 2013;7:71-6.

Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA. 2000 Apr 12;283(14):1829-36.

Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest. 2005 Jun 1;127(6):2076-84.

Ravidran C, Arun P, Hari L. Syndrome Z - the new metabolic syndrome. Calicut Med J. 2007;5(1):e1.